(Q43091072)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407744%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407744%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407744%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Paul J Veugelers

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407744%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

S L Bowker

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407744%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Y Yasui

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407744%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

21 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407744%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407744%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407744%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407744%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

1631-1637

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407744%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00125-010-1750-8

31 January 2020

exact match

0 references

cites work

Metformin decelerates aging and development of mammary tumors in HER-2/neu transgenic mice

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-010-1750-8

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

21 January 2018

1 reference

12 December 2020

Diabetes mellitus and risk of colorectal cancer: a meta-analysis

1 reference

12 December 2020

Insulin therapy and colorectal adenoma risk among patients with Type 2 diabetes mellitus: a case-control study in Korea

1 reference

12 December 2020

HUMAN MAMMARY SLICES IN ORGAN CULTURE. I. METHOD OF CULTURE AND PRELIMINARY OBSERVATIONS ON THE EFFECT OF INSULIN

1 reference

12 December 2020

A chronic disease score from automated pharmacy data

1 reference

12 December 2020

Antidiabetic therapies affect risk of pancreatic cancer

1 reference

12 December 2020

Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults

1 reference

12 December 2020

Oral Antidiabetic Agents

1 reference

12 December 2020

Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

1 reference

12 December 2020

Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer

1 reference

12 December 2020

Type of antidepressant therapy and risk of type 2 diabetes in people with depression.

1 reference

12 December 2020

Diabetes mellitus and risk of breast cancer: a meta-analysis

1 reference

12 December 2020

Prevention of pancreatic cancer induction in hamsters by metformin

1 reference

12 December 2020

Diabetes mellitus and risk of bladder cancer: a meta-analysis

1 reference

12 December 2020

Insulin use and increased risk of mortality in type 2 diabetes: a cohort study.

1 reference

12 December 2020

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis

1 reference

12 December 2020

Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients

1 reference

12 December 2020

Insulin and insulin-like growth factor signalling in neoplasia

1 reference

12 December 2020

Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies.

1 reference

12 December 2020

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

1 reference

12 December 2020

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

1 reference

12 December 2020

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

1 reference

12 December 2020

No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis

1 reference

12 December 2020

Combined randomised controlled trial experience of malignancies in studies using insulin glargine

1 reference

12 December 2020

Diabetes mellitus and risk of endometrial cancer: a meta-analysis

1 reference

12 December 2020

Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth

1 reference

12 December 2020

Survival Bias Associated with Time-to-Treatment Initiation in Drug Effectiveness Evaluation: A Comparison of Methods

1 reference

12 December 2020

Managing type 2 diabetes: going beyond glycemic control

1 reference

12 December 2020

Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen

1 reference

12 December 2020

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

1 reference

12 December 2020

Metformin and reduced risk of cancer in diabetic patients

1 reference

12 December 2020

Insulin glargine and malignancy: an unwarranted alarm

1 reference

12 December 2020

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

1 reference

12 December 2020

The darkening cloud of diabetes: do trends in cardiovascular risk management provide a silver lining?

1 reference

12 December 2020

Insulin in the adjuvant breast cancer setting: a novel therapeutic target for lifestyle and pharmacologic interventions?

1 reference

12 December 2020

Time-dependent bias was common in survival analyses published in leading clinical journals.

1 reference

12 December 2020

AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease

1 reference

12 December 2020